Aytu Bioscience Stock Earnings Per Share

AYTU Stock

USD 1.65 0.05 2.94%

Aytu BioScience fundamentals help investors to digest information that contributes to Aytu BioScience's financial success or failures. It also enables traders to predict the movement of Aytu Stock. The fundamental analysis module provides a way to measure Aytu BioScience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aytu BioScience stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Aytu BioScience Company Earnings Per Share Analysis

Aytu BioScience's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

Earnings per Share

Earnings

Average Shares

More About Earnings Per Share | All Equity Analysis

Current Aytu BioScience Earnings Per Share

(1.70) X

Most of Aytu BioScience's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aytu BioScience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Aytu Earnings Per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for Aytu BioScience is extremely important. It helps to project a fair market value of Aytu Stock properly, considering its historical fundamentals such as Earnings Per Share. Since Aytu BioScience's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aytu BioScience's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aytu BioScience's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Current Deferred Revenue	Capital Surpluse	Intangible Assets	Property Plant Equipment	Net Receivables	Good Will	Deferred Long Term Liab	Long Term Debt	Short Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Debt Total
Total Assets		0.92	-0.56	-0.72	0.97	0.95	0.98	0.67	-0.43	-0.26	0.83	0.86	0.96	0.87	0.85	0.83	-0.68	0.33	-0.63	0.57	0.97	0.18	0.3	-0.25
Total Stockholder Equity	0.92		-0.74	-0.41	0.89	0.74	0.87	0.74	-0.35	0.06	0.6	0.64	0.84	0.68	0.59	0.55	-0.52	0.13	-0.48	0.65	0.97	0.35	0.53	0.03
Net Debt	-0.56	-0.74		0.13	-0.55	-0.34	-0.56	-0.27	0.3	-0.56	-0.04	-0.44	-0.44	-0.1	-0.13	-0.19	0.42	-0.19	0.38	-0.15	-0.63	-0.85	-0.85	-0.09
Retained Earnings	-0.72	-0.41	0.13		-0.72	-0.89	-0.8	-0.17	0.49	0.61	-0.84	-0.93	-0.81	-0.78	-0.92	-0.96	0.78	-0.7	0.74	-0.04	-0.57	0.03	0.07	0.58
Accounts Payable	0.97	0.89	-0.55	-0.72		0.92	0.96	0.61	-0.44	-0.27	0.84	0.83	0.97	0.83	0.84	0.78	-0.69	0.38	-0.63	0.49	0.92	0.19	0.31	-0.09
Total Liab	0.95	0.74	-0.34	-0.89	0.92		0.96	0.54	-0.45	-0.5	0.92	0.93	0.95	0.93	0.97	0.96	-0.74	0.46	-0.68	0.43	0.86	0.02	0.08	-0.43
Total Current Assets	0.98	0.87	-0.56	-0.8	0.96	0.96		0.56	-0.44	-0.26	0.82	0.91	0.95	0.84	0.89	0.88	-0.71	0.41	-0.66	0.45	0.94	0.24	0.31	-0.33
Short Term Debt	0.67	0.74	-0.27	-0.17	0.61	0.54	0.56		-0.3	-0.2	0.52	0.32	0.58	0.68	0.45	0.35	-0.21	-0.31	-0.16	0.94	0.72	-0.24	-0.01	0.0
Common Stock	-0.43	-0.35	0.3	0.49	-0.44	-0.45	-0.44	-0.3		0.16	-0.32	-0.59	-0.48	-0.34	-0.36	-0.4	0.63	-0.49	0.58	0.01	-0.32	-0.15	-0.09	0.18
Net Tangible Assets	-0.26	0.06	-0.56	0.61	-0.27	-0.5	-0.26	-0.2	0.16		-0.68	-0.36	-0.39	-0.64	-0.63	-0.59	0.37	-0.3	0.34	-0.19	-0.11	0.73	0.72	0.33
Current Deferred Revenue	0.83	0.6	-0.04	-0.84	0.84	0.92	0.82	0.52	-0.32	-0.68		0.76	0.9	0.96	0.95	0.88	-0.58	0.38	-0.54	0.46	0.72	-0.28	-0.13	-0.26
Capital Surpluse	0.86	0.64	-0.44	-0.93	0.83	0.93	0.91	0.32	-0.59	-0.36	0.76		0.88	0.77	0.87	0.93	-0.86	0.67	-0.81	0.15	0.75	0.24	0.21	-0.53
Intangible Assets	0.96	0.84	-0.44	-0.81	0.97	0.95	0.95	0.58	-0.48	-0.39	0.9	0.88		0.9	0.88	0.86	-0.73	0.46	-0.67	0.44	0.89	0.11	0.24	-0.18
Property Plant Equipment	0.87	0.68	-0.1	-0.78	0.83	0.93	0.84	0.68	-0.34	-0.64	0.96	0.77	0.9		0.92	0.87	-0.59	0.27	-0.56	0.62	0.81	-0.29	-0.11	-0.35
Net Receivables	0.85	0.59	-0.13	-0.92	0.84	0.97	0.89	0.45	-0.36	-0.63	0.95	0.87	0.88	0.92		0.96	-0.65	0.44	-0.61	0.38	0.74	-0.16	-0.12	-0.48
Good Will	0.83	0.55	-0.19	-0.96	0.78	0.96	0.88	0.35	-0.4	-0.59	0.88	0.93	0.86	0.87	0.96		-0.72	0.53	-0.68	0.27	0.7	-0.04	-0.04	-0.59
Deferred Long Term Liab	-0.68	-0.52	0.42	0.78	-0.69	-0.74	-0.71	-0.21	0.63	0.37	-0.58	-0.86	-0.73	-0.59	-0.65	-0.72		-0.82	0.97	0.0	-0.59	-0.27	-0.2	0.32
Long Term Debt	0.33	0.13	-0.19	-0.7	0.38	0.46	0.41	-0.31	-0.49	-0.3	0.38	0.67	0.46	0.27	0.44	0.53	-0.82		-0.85	-0.5	0.2	0.32	0.17	-0.22
Short Term Investments	-0.63	-0.48	0.38	0.74	-0.63	-0.68	-0.66	-0.16	0.58	0.34	-0.54	-0.81	-0.67	-0.56	-0.61	-0.68	0.97	-0.85		0.03	-0.56	-0.27	-0.18	0.3
Short Long Term Debt	0.57	0.65	-0.15	-0.04	0.49	0.43	0.45	0.94	0.01	-0.19	0.46	0.15	0.44	0.62	0.38	0.27	0.0	-0.5	0.03		0.65	-0.33	-0.09	0.01
Net Invested Capital	0.97	0.97	-0.63	-0.57	0.92	0.86	0.94	0.72	-0.32	-0.11	0.72	0.75	0.89	0.81	0.74	0.7	-0.59	0.2	-0.56	0.65		0.24	0.4	-0.16
Net Working Capital	0.18	0.35	-0.85	0.03	0.19	0.02	0.24	-0.24	-0.15	0.73	-0.28	0.24	0.11	-0.29	-0.16	-0.04	-0.27	0.32	-0.27	-0.33	0.24		0.89	0.12
Capital Stock	0.3	0.53	-0.85	0.07	0.31	0.08	0.31	-0.01	-0.09	0.72	-0.13	0.21	0.24	-0.11	-0.12	-0.04	-0.2	0.17	-0.18	-0.09	0.4	0.89		0.25
Long Term Debt Total	-0.25	0.03	-0.09	0.58	-0.09	-0.43	-0.33	0.0	0.18	0.33	-0.26	-0.53	-0.18	-0.35	-0.48	-0.59	0.32	-0.22	0.3	0.01	-0.16	0.12	0.25

Click cells to compare fundamentals

Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.

Competition

Predict Aytu BioScience

Aytu BioScience Earnings Estimates

Aytu Common Stock Shares Outstanding

Common Stock Shares Outstanding

5.81 Million

At this time, Aytu BioScience's Common Stock Shares Outstanding is comparatively stable compared to the past year.

According to the company disclosure, Aytu BioScience has an Earnings Per Share of -1.7 times. This is 120.31% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The earnings per share for all United States stocks is 154.49% higher than that of the company.

Aytu Earnings Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aytu BioScience's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aytu BioScience could also be used in its relative valuation, which is a method of valuing Aytu BioScience by comparing valuation metrics of similar companies.

Aytu BioScience is currently under evaluation in earnings per share category among its peers.

Aytu Fundamentals

	Return On Equity	-0.47
	Return On Asset	-0.0106
	Profit Margin	(0.20) %
	Operating Margin	(0.04) %
	Current Valuation	6.6 M
	Shares Outstanding	6.15 M
	Shares Owned By Insiders	2.43 %
	Shares Owned By Institutions	34.04 %
	Number Of Shares Shorted	120.8 K
	Price To Earning	(0.77) X
	Price To Book	0.34 X
	Price To Sales	0.13 X
	Revenue	81 M
	Gross Profit	66.63 M
	EBITDA	(1.01 M)
	Net Income	(15.84 M)
	Cash And Equivalents	23.81 M
	Cash Per Share	0.38 X
	Total Debt	15.13 M
	Debt To Equity	0.47 %
	Current Ratio	1.02 X
	Book Value Per Share	4.64 X
	Cash Flow From Operations	(1.39 M)
	Short Ratio	10.45 X
	Earnings Per Share	(1.70) X
	Target Price	8.0
	Number Of Employees	102
	Beta	-1.4
	Market Capitalization	10.45 M
	Total Asset	118.09 M
	Retained Earnings	(319.97 M)
	Working Capital	(337 K)
	Current Asset	6.36 M
	Current Liabilities	8.73 M
	Net Asset	118.09 M

About Aytu BioScience Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Aytu BioScience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aytu BioScience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aytu BioScience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Aytu Stock Analysis

When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC